Susan E. Hahn
38Patents
6h-index
19Co-inventors
58Inventor score
Filing activity: Jan 21, 2003 → Aug 16, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7420041B2 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 | Chemistry; Metallurgy | 46 | Active |
| US7420040B2 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 | Chemistry; Metallurgy | 42 | Active |
| US7456016B2 | Cancerous disease modifying antibodies | Human Necessities | 9 | Active |
| US7189825B2 | Cancerous disease modifying antibodies | Human Necessities | 8 | Expired |
| US7431923B2 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Physics | 6 | Expired |
| US7393531B2 | Cytotoxicity mediation of cells evidencing surface expression of MCSP | Human Necessities | 6 | Expired |
| US7442777B2 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Physics | 6 | Expired |
| US7189397B2 | Cytotoxicity mediation of cells evidencing surface expression of CD44 | Human Necessities | 5 | Expired |
| US7252821B2 | Cancerous disease modifying antibodies | Human Necessities | 5 | Expired |
| US7009040B2 | Cancerous disease modifying antibodies | Human Necessities | 4 | Expired |
| US7399835B2 | Cancerous disease modifying antibodies | Human Necessities | 3 | Expired |
| US7507537B2 | Cytotoxicity mediation of cells evidencing surface expression of CD44 | Chemistry; Metallurgy | 2 | Active |
| US7468254B2 | Cytotoxicity mediation of cells evidencing surface expression of MCSP | Chemistry; Metallurgy | 2 | Expired |
| US7442776B2 | Cancerous disease modifying antibodies | Chemistry; Metallurgy | 2 | Expired |
| US8071072B2 | Cytotoxicity mediation of cells evidencing surface expression of CD44 | Physics | 1 | Active |
| US7361342B2 | Cancerous disease modifying antibodies | Human Necessities | 1 | Expired |
| US8017117B2 | Cytotoxicity mediation of cells evidencing surface expression of CD44 | Physics | 1 | Active |
| US6794494B1 | Cancerous disease modifying antibodies | Human Necessities | 1 | Expired |
| US7256271B2 | Cancerous disease modifying antibodies | Physics | 0 | Expired |
| US7452978B2 | Cancerous disease modifying antibodies | Chemistry; Metallurgy | 0 | Active |
| US8277803B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Active |
| US7947496B2 | Cytotoxicity mediation of cells evidencing surface expression of CD44 | Physics | 0 | Active |
| US7186808B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Expired |
| US8003761B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Active |
| US7195764B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.